NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Membrana

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Membrana-Charlotte Launched Expanded Website for Liqui-Cel® Membrane Contactors - Liqui-Cel.com - Membrana-Charlotte, a leading membrane and degassing device manufacturer has expanded its Liqui-Cel® Business Unit’s website improving its functionality and visual appearance - Liqui-Cel.com / Membrana.com
Membrana-Charlotte Launched Expanded Website for Liqui-Cel® Membrane Contactors - Liqui-Cel.com

 

NewswireTODAY - /newswire/ - Charlotte, NC, United States, 2010/12/08 - Membrana-Charlotte, a leading membrane and degassing device manufacturer has expanded its Liqui-Cel® Business Unit’s website improving its functionality and visual appearance - Liqui-Cel.com / Membrana.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The new website has additional information as well as an updated visual appearance. Over the years Membrana has added many new gas transfer products to their product portfolio to meet the specific needs of a variety of industries. New brand landing pages have been added so that it is easier to find and learn more about the various products and how they operate. Additionally, the new brand pages incorporate animated Flash segments demonstrating the flow paths inside of the different membrane contactor designs.

The updated website is organized so that customers can obtain all product information by primary applications or by the industry where Liqui-Cel® Membrane Contactors are used. The new website makes it easier for users to identify and select information based on their specific needs. Each industry and application area contains background information as well as quick links to technical content including data sheets, technical briefs and technical papers specific to the various industries and applications. Additionally, a section for Frequently Asked Question has been set up which allows the user to search by their topic of interest.

Liqui-Cel®, MicroModule®, MiniModule®, and SuperPhobic® Membrane Contactors are used around the world for adding or removing oxygen (O2), carbon dioxide (CO2) and nitrogen (N2) to or from different liquids in digital printing, analytical/biotechnology, semiconductor, power, pharmaceutical, photographic, food and beverage, and many other industries. For example, O2 negatively impacts many processes; it is corrosive and can oxidize materials. In the power and industrial areas, piping and equipment are susceptible to corrosion. Specifically to the semiconductor and ink market, high levels of dissolved gases can cause lower yields and slower process speeds.

Liqui-Cel® Contactors (liqui-cel.com) are also used to add gasses to liquids to enhance megasonic cleaning. The beverage industry looks to membrane contactors for carbonation, nitrogenation and deoxygenation. These reflect only a few examples of the variety of applications where Membrana Membrane Contactors are used.

Membrana’s Filtration Group also manufactures a variety of membranes and devices used for filtration in various industries and applications.

Membrana-Charlotte, is a division of Celgard, LLC of Charlotte, North Carolina and is A POLYPORE Company. Polypore International, Inc. is a global high technology filtration company specializing in microporous membranes. Polypore's flat sheet and hollow fiber membranes are used in specialized applications that require the removal or separation of various materials from liquids, primarily in the ultrafiltration and microfiltration markets. Based in Charlotte, North Carolina, Polypore International, Inc. is a global leader with manufacturing facilities or sales offices in nine countries serving six continents.

Membrana - Charlotte maintains the website, liqui-cel.com for information, education, and communication. Access and use of the website is subject to the Site Terms and Conditions. The site may contain links to other sites and Membrana is not responsible for the privacy practices or content of such other sites. Liqui-Cel, SuperPhobic, MiniModule, and MicroModule, are registered trademarks of Membrana-Charlotte, a Division of Celgard, LLC.

Membrana (membrana.com) has been manufacturing membrane contactors for over 20 years and is recognized as the leader in membrane degassing technology.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Membrana

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Membrana-Charlotte Launched Expanded Website for Liqui-Cel® Membrane Contactors - Liqui-Cel.com

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Scott Willis - Membrana.com 
704-587-8888 scott.willis.lc[.]membrana.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Membrana securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Membrana / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit BizJobs.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)